Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)

ClinicalTrials.gov ID: NCT05706506

Public ClinicalTrials.gov record NCT05706506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 4:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Single-Arm, Phase 4 Study to Assess Glycemic Control When Adults With Type 2 Diabetes Switch From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to investigate the effects of switching from glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy to tirzepatide glucose-dependent insulinotropic polypeptide (GIP) GLP-1 RA agonist in participants with type 2 diabetes (T2D).

Study identification

NCT ID
NCT05706506
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
152 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 8, 2023 (Actual)
Primary completion
Oct 31, 2023 (Actual)
Completion
Oct 31, 2023 (Actual)
Last update posted
Dec 13, 2024

2023

United States locations

U.S. sites
32
U.S. states
16
U.S. cities
31
Facility City State ZIP Site status
Fiel Family and Sports Medicine PC Tempe Arizona 85283 —
New Hope Research Development Corona California 92882 —
Velocity Clinical Research, Gardena Gardena California 90247 —
Velocity Clinical Research, Huntington Park Huntington Park California 90255 —
Velocity Clinical Research, Huntington Park Los Angeles California 90057 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Dream Team Clinical Research Pomona California 91767 —
Scripps Whittier Diabetes Institute San Diego California 92121-1520 —
Metabolic Institute of America Tarzana California 91356-3551 —
CMR of Greater New Haven, LLC Waterbury Connecticut 06708 —
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009 —
East Coast Institute for Research, LLC Jacksonville Florida 32204 —
Florida Institute For Clinical Research, LLC Orlando Florida 32825 —
New Tampa Health Tampa Florida 33603-3402 —
Georgia Clinical Research Lawrenceville Georgia 30044-5896 —
Endocrine Research Solutions, Inc. Roswell Georgia 30076 —
Velocity Clinical Research, Valparaiso Valparaiso Indiana 46383 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Cotton O'Neil Clinic Topeka Kansas 66606 —
Versailles Family Medicine Versailles Kentucky 40383-1947 —
Endocrine and Metabolic Consultants Rockville Maryland 20852 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Clinical Research of South Nevada Las Vegas Nevada 89121 —
Palm Research Center Tenaya Las Vegas Nevada 89128 —
Advanced Medical Research Maumee Ohio 43537-9402 —
Conrad Clinical Research Edmond Oklahoma 73013 —
Mountain View Clinical Research, Inc. Greenville South Carolina 29607 —
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731-4309 —
North Texas Endocrine Center Dallas Texas 75231 —
Memorial City Endocrine Consultants Houston Texas 77043-2742 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
ClinPoint Trials Waxahachie Texas 75165 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05706506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05706506 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →